NIH-funded research R37 grant

Investigating how circadian rhythms affect liver cancer progression from fatty liver disease

Official title: 3D Circadian Enhancer-Promoter Interactions Mediated by ESRRG in NAFLD-to-HCC Progression

Funded at Baylor College of Medicine · NIH-11028722 · Data updated 2026-11-12

This study is looking at how our body's natural clock affects the progression of nonalcoholic fatty liver disease to liver cancer, hoping to find new ways to improve treatment for patients with NAFLD.

More NAFLD research and trials

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine
NIH-funded
Lab location1 site (Houston, United States)
Project startJune 1, 2025
Project endMay 31, 2030
Funding year2025
Award (this year)$483,077
NIH project number1R37CA296577-01
Project IDNIH-11028722 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with nonalcoholic fatty liver disease (NAFLD) or its more severe form, nonalcoholic steatohepatitis (NASH).

Less likely to help

Patients without any liver disease or those with other unrelated health conditions may not benefit from this research.

What this research studies

This research explores the relationship between circadian rhythms and the progression of nonalcoholic fatty liver disease (NAFLD) to hepatocellular carcinoma (HCC). It focuses on understanding how disruptions in these rhythms may contribute to cancer development. By analyzing gene interactions and the role of specific transcription factors, the study aims to uncover new insights into the mechanisms behind this progression. Patients with NAFLD may benefit from findings that could lead to improved treatment strategies based on timing and circadian biology.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic approaches that optimize treatment timing for patients with liver disease, potentially reducing the risk of developing liver cancer.

How similar studies have gone: Previous research has shown promising results in understanding the role of circadian rhythms in cancer development, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Baylor College of Medicine
    Houston, United States
    Active

Researchers

  • Principal investigator: Guan, Dongyin — Baylor College of Medicine
  • Study coordinator: Guan, Dongyin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.